← Back to Search

Scoliosis-Specific Exercises for At-Risk AIS Curves (EX Trial)

N/A
Waitlist Available
Led By Karina Zapata, PhD
Research Sponsored by Texas Scottish Rite Hospital for Children
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare the effects of scoliosis-specific exercises to the standard-of-care method for treating mild AIS curves in skeletally immature patients.

Eligible Conditions
  • Adolescent Idiopathic Scoliosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Home exercise adherence in the SSE group according to a smartphone application
Home exercise adherence in the SSE group according to weekly e-mails
Overall recruitment rate
+2 more
Secondary study objectives
Brace prescription
Curve magnitude
Curve progression

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Physical Therapy Exercise GroupExperimental Treatment1 Intervention
Each patient assigned to the SSE group will attend at least 8 hours of supervised exercise training led by a Schroth-based certified physical therapist over the course of 6 months. Ideally, patients will be seen for 7 sessions. Patients will perform a home exercise program for 15 minutes a day, 5 days a week, when they can independently execute their prescribed exercises. An exercise log initialed by the guardian will help families keep track of their exercise adherence and serve as a way to monitor exercise adherence for patients who may not have a smartphone, tablet, or computer. Patients will also be able to meet with the therapists at their return-to-clinic visits and every 2-3 months thereafter until their 1 year follow-up to assess performance quality, maintain motivation, and progress intensity. Patients will be withdrawn if they do not achieve 80% exercise adherence within 6 months.
Group II: Control GroupActive Control1 Intervention
Patients randomized to this group will continue receiving standard-of-care treatment from their orthopaedic physician which includes regularly scheduled clinic visits and observation. Observation consists of no treatment of the scoliosis, only routine clinical assessment by the orthopaedic surgeon to detect curve progression every 3 to 6 months.

Find a Location

Who is running the clinical trial?

Boston Children's HospitalOTHER
788 Previous Clinical Trials
5,582,477 Total Patients Enrolled
Johns Hopkins UniversityOTHER
2,332 Previous Clinical Trials
14,874,806 Total Patients Enrolled
Columbia UniversityOTHER
1,492 Previous Clinical Trials
2,664,764 Total Patients Enrolled
Baylor College of MedicineOTHER
1,025 Previous Clinical Trials
6,029,685 Total Patients Enrolled
Norton Leatherman Spine CenterOTHER
5 Previous Clinical Trials
683 Total Patients Enrolled
Texas Scottish Rite Hospital for ChildrenLead Sponsor
21 Previous Clinical Trials
8,928 Total Patients Enrolled
Scoliosis Research SocietyOTHER
7 Previous Clinical Trials
710 Total Patients Enrolled
Karina Zapata, PhDPrincipal InvestigatorScottish Rite for Children

Media Library

Scoliosis Specific Exercises Clinical Trial Eligibility Overview. Trial Name: NCT02807545 — N/A
Adolescent Idiopathic Scoliosis Research Study Groups: Physical Therapy Exercise Group, Control Group
Adolescent Idiopathic Scoliosis Clinical Trial 2023: Scoliosis Specific Exercises Highlights & Side Effects. Trial Name: NCT02807545 — N/A
Scoliosis Specific Exercises 2023 Treatment Timeline for Medical Study. Trial Name: NCT02807545 — N/A
~10 spots leftby Dec 2025